Age-Related Macular Degeneration, a Mathematically Tractable Disease

19Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

A progression sequence for age-related macular degeneration onset may be determinable with consensus neuroanatomical nomenclature augmented by drusen biology and eye-tracked clinical imaging. This narrative review proposes to supplement the Early Treatment of Diabetic Retinopathy Study (sETDRS) grid with a ring to capture high rod densities. Published photoreceptor and retinal pigment epithelium (RPE) densities in flat mounted aged-normal donor eyes were recomputed for sETDRS rings including near-periphery rich in rods and cumulatively for circular fovea-centered regions. Literature was reviewed for tissue-level studies of aging outer retina, populationlevel epidemiology studies regionally assessing risk, vision studies regionally assessing rod-mediated dark adaptation (RMDA), and impact of atrophy on photopic visual acuity. The 3 mm-diameter xanthophyll-rich macula lutea is rod-dominant and loses rods in aging whereas cone and RPE numbers are relatively stable. Across layers, the largest aging effects are accumulation of lipids prominent in drusen, loss of choriocapillary coverage of Bruch's membrane, and loss of rods. Epidemiology shows maximal risk for drusen-related progression in the central subfield with only one third of this risk level in the inner ring. RMDA studies report greatest slowing at the perimeter of this highrisk area. Vision declines precipitously when the cone-rich central subfield is invaded by geographic atrophy. Lifelong sustenance of foveal cone vision within the macula lutea leads to vulnerability in late adulthood that especially impacts rods at its perimeter. Adherence to an sETDRS grid and outer retinal cell populations within it will help dissect mechanisms, prioritize research, and assist in selecting patients for emerging treatments.

References Powered by Scopus

The hallmarks of aging

10807Citations
N/AReaders
Get full text

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

2878Citations
N/AReaders
Get full text

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement fromthe European Atherosclerosis Society Consensus Panel

2618Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration

14Citations
N/AReaders
Get full text

Quantification of Human Photoreceptor–Retinal Pigment Epithelium Macular Topography with Adaptive Optics–Optical Coherence Tomography

3Citations
N/AReaders
Get full text

Aging of the eye: Lessons from cataracts and age-related macular degeneration

3Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Curcio, C. A., Kar, D., Owsley, C., Sloan, K. R., & Ach, T. (2024). Age-Related Macular Degeneration, a Mathematically Tractable Disease. Investigative Ophthalmology and Visual Science, 65(3 MARCH). https://doi.org/10.1167/iovs.65.3.4

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

60%

Professor / Associate Prof. 3

30%

Researcher 1

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

67%

Biochemistry, Genetics and Molecular Bi... 2

17%

Agricultural and Biological Sciences 1

8%

Neuroscience 1

8%

Save time finding and organizing research with Mendeley

Sign up for free